Impact of Emphysema Severity on Clinicopathological and Molecular Features in Non–small Cell Lung Cancer
Anticancer Research · 2025-12 · 45 (12) · 5655-5666
DOI: 10.21873/anticanres.17899 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.11.2025. Verfasst von Yoshiyuki Yasuura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan; yoshikenkazu@yahoo.co.jp. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Pulmonary Emphysema. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan; yoshikenkazu@yahoo.co.jp.
- Department of Surgery, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
- Department of Thoracic Surgery, Yokohama City University Medical Center, Yokohama, Japan.
Zitieren
APA
Yasuura, Y., Woo, T., Tanaka, S., Masuda, H., Kameda, Y., Inafuku, K., & Saito, A. (2025). Impact of Emphysema Severity on Clinicopathological and Molecular Features in Non–small Cell Lung Cancer. Anticancer Research, 45(12), 5655-5666. https://doi.org/10.21873/anticanres.17899
Vancouver
Yasuura Y, Woo T, Tanaka S, Masuda H, Kameda Y, Inafuku K, et al. Impact of Emphysema Severity on Clinicopathological and Molecular Features in Non–small Cell Lung Cancer. Anticancer Research. 2025;45(12):5655-5666. doi:10.21873/anticanres.17899
BibTeX
@article{Yasuura2025,
author = {Yasuura, Yoshiyuki and Woo, Tetsukan and Tanaka, Shoma and Masuda, Haruhiko and Kameda, Yohei and Inafuku, Kenji and Saito, Aya},
title = {Impact of Emphysema Severity on Clinicopathological and Molecular Features in Non–small Cell Lung Cancer},
journal = {Anticancer Research},
year = {2025},
volume = {45},
number = {12},
pages = {5655--5666},
doi = {10.21873/anticanres.17899}
}
EUVIMED